Abstract. The ellipsoidal shape of the yeast Saccharomyces cerevisiae is the result of successive isotropic/apical growth switches that are regulated in a cell cycledependent manner. It is thought that growth polarity is governed by the remodeling of the actin cytoskeleton that is itself under the control of the cell cycle machinery. The cell cycle and the morphogenesis cycle are tightly coupled and it has been recently suggested that a morphogenesis/polarity checkpoint control monitors bud emergence in order to maintain the coupling of these two events (Lew, D. J., and S. I. Reed. 1995. J. Cell BioL 129:739-749). During a screen based on the inability of cells impaired in the budding process to survive when the morphogenesis checkpoint control is abolished, we identified and characterized BED1, a new gene that is required for efficient budding. Cells carrying a disrupted allele of BED1 no longer have the wild-type ellipsoidal shape characteristic of S. cerevisiae, are larger than wild-type cells, are deficient in bud emergence, and depend upon an intact morphogenesis checkpoint control to survive. These cells show defects in polarized growth despite the fact that the actin cytoskeleton appears normal. Our results suggest that Bedl is a type II membrane protein localized in the endoplasmic reticulum. BED1 is significantly homologous to gma12 ÷, a S. pombe gene coding for an et-l,2-galactosyltransferase, suggesting that glycosylation of specific proteins or lipids could be important for signaling in the switch to polarized growth and in bud emergence.
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T
HE ellipsoidal shape of the yeast Saccharomyces cerevisiae reflects cell cycle-regulated polarized growth. At specific times during the cell cycle, cell growth is either isotropic or polarized toward the bud (for review see Lew and Reed, 1995b) . A correlation between local deposition of new cell wall components and actin localization has been established (Adams and Pringle, 1984; Kilmartin and Adams, 1984) , leading to the proposal that actin directs secretory vesicles to specific regions of the plasma membrane to allow localized cell surface growth during bud initiation and bud growth. During most of the G1 phase, growth is isotropic and cortical actin patches are delocalized throughout the cell. The attainment of a critical cell size and concomitant execution of START lead to the formation of an actin ring at the pre-bud site and the orientation of actin filaments toward this site. Subsequent to START, growth is almost completely restricted to the emerging bud. During bud growth, cortical actin patches are localized to the bud. Initially, bud growth occurs primarily at the distal tip. At some point, though, there is a switch to isotropic growth first in the bud, then also tran-siently in the mother cell at mitosis. At cytokinesis, the actin cytoskeleton is reorganized and actin patches are relocalized to the mother-daughter neck where the cell wall is modified for cell separation. The mechanisms by which actin mediates polarized secretion are not well understood, but it has been shown that cortical actin patches are associated with the cell surface through an invagination of the plasma membrane (Mulholland et al., 1994) and it has been suggested that components of the secretory pathway (endoplasmic reticulum [ER] and Golgi) could be transported into the bud to direct localized growth presumably via an actin-dependent mechanism (Preuss et al., 1992) .
A variety of proteins have been shown to be required for either bud emergence or for bud site selection (for recent reviews see Bretscher et al., 1994; Chant, 1994; Welch and Drubin, 1994) . CDC42, encoding a small GTP-binding protein, and several genes encoding its regulators are involved in bud emergence: cells mutated in these genes arrest as large unbudded cells with a disorganized actin cytoskeleton and delocalized chitin. The BUD genes, along with CDC24 and RSV167 are involved in the selection of the bud site.
In S. cerevisiae, the budding cycle is tightly coupled to the central events of the cell cycle. Upon completion of the primary G1 restriction event known as START, when the mother cell has reached a critical size, bud emergence and S phase are initiated (Nasmyth, 1993; Reed, 1992) . Moreover, the dramatic changes of actin organization and the isotropic/apical growth switches observed during the cell cycle have been shown to be triggered by the different forms of the Cdc28 kinase that constitute the cell cycle clock . Furthermore, it has been recently suggested that growth polarity or bud emergence are monitored to ensure that mitosis does not occur before a bud is produced to receive the daughter nucleus (Lew and Reed, 1995a) . The impairment of growth polarity either by mutation or external stimuli such as osmotic shock is detected and results in a G2 delay. This morphogenesis/ polarity checkpoint control is mediated via a partial inhibition of transcription of the mitotic cyclin genes CLB1 and CLB2 and also through a more direct inhibition of the mitotic form of the Cdc28 kinase via negative regulatory phosphorylation of Tyrl9 of Cdc28 (Lew and Reed, 1995a) . This conserved tyrosine has been shown to be the target of negative regulatory phosphorylation for a number of different cyclin-dependent kinases.
In this paper, we describe the identification and the characterization of a new gene called BED1 (which stands for Bud Emergence Delay) 1 that is required for efficient polarized growth and is important for bud emergence. The bed1-1 mutation was isolated based on synthetic lethality with overexpression of mitotic cyclins, a phenotype that occurs because bed1 mutant cells depend on the morphogenesis/polarity checkpoint which overexpression of mitotic cyclins overrides. We have shown that the Bed1 protein is an integral membrane protein localized in the endoplasmic reticulum. This protein shares homology with a previously described S. pombe o~-l,2-galactosyltransferase. Our results suggest that glycosyl modification could play a role in regulating growth polarity and bud emergence.
Materials and Methods

Yeast Strains, Media, and Growth Conditions
All strains used in this study were derivatives of BF264-15DU: MATa adel, his2, 112, ura3Dns (Richardson et al., 1989) . The relevant genotypes of strains used in this study are shown in Table I . Yeast cultures were grown at 30°C in YEP (1% yeast extract, 2% bactopeptone, 0.005% adenine, 0.005% uracil) supplemented with 2% glucose (YEPD), raffinose (YEPR), or galactose (YEPG). Genes under control of the GALl promoter were induced by the addition of 2% galactose to a midlog phase culture (YEPR) for 4 h.
Identification and Molecular Characterization of the
BED1 Gene
A strain carrying a GALI:CLB2 allele (GY-1) was mutagenized by ultraviolet radiation (70% death) on YEPD plates (GALl promoter repressed) and incubated at 30°C for 2 d. The colonies were then replicaplated to YEPG (GALl promoter induced). Out of 25,000 colonies screened, 20 were unable to grow on galaetose. Based on the level of Clb2 overexpression, we discarded 11 candidates that showed low levels of Clb2 protein after 4 h galactose induction of the GAL:CLB2 allele, presumably because the mutations affected the galactose pathway. The nine remaining candidates were then crossed to the wild-type 15D strain and the resulting tetrads were analyzed to show that, for eight of them, the lethality was associated with overexpression of Clb2. The mutant strains were backcrossed to a MATa-GALI:CLB2 strain (GY-101) and the diploid strains were then induced to sporulate and meiotic asci dissected to verify that the lethality on YEPG was due to a single mutation and that the mutations were not localized to the GALI:CLB2 locus. A complementation analysis with the 8 remaining candidates showed that they belong to 6 different complementation groups, 2 of them with 2 alleles. We analyzed in greater detail one of them, that contains one allele, bedl-l.
The BED1 gene was cloned by complementation of the lethality of the strain GY-159 (GALI:CLB2-bedl-1) on YEPG plates with a YCp50 based genomic yeast DNA library (Rose et al., 1987) . The screening of 15,000 transformants (the equivalent of 10 genomes) yielded the plasmid pR159.1 5 times and the plasmid pR159.5 a single time, containing inserts of 12 kb and 9 kb, respectively (see Fig. 7 A) . These two DNA fragments had an overlap a region of 2.7 kb that was able to rescue the lethality of the strain GY-159 on YEPG medium. This region was sequenced on both strands using an automated sequencing system (Applied Biosystems, Foster City, CA 
Plasmids
The 2.7-kb DNA fragment defined by the region of overlap between plasmids pR159.1 and pR159.5 was subcloned into pBlueScript (Stratagene, La Jolla, CA) and the BED1 gene was disrupted by replacing an 0.8-kb XbaI fragment within the coding region with a HindIII DNA fragment containing the URA3 gene to give the plasmid pBS159::URA3C (see Fig. 1 B) . The BED10RF was amplified by PCR using primers containing BamHI sites and a unique NotI site before the STOP codon (primers: 5'-CCC-CGGATCCACAATATGTCTAGTGTACCT-3 '; 5'-CCCCGGATCCITA-GCGGCCGCCTGGGAAGAAAAATCTCGTGT-3'; the BamHI and NotI sites are indicated in bold characters and the ATG and STOP codons are underlined). The PCR product cloned into the pCRII vector (Invitrogen, San Diego, CA) and digested with BamHI was then cloned into the BamHI site of YIpG2 (LEU2) (Richardson et al., 1989) , into the BglII site of pHV100 (URA3) (Sikorski and Hieter, 1989) . A Notl fragment containing three tandem copies of the HA epitope from the plasmid pGTEP1 (Tyers et al., 1992) 
Strain Construction
Strains were constructed according to standard genetic procedures (Sherman et al., 1982) except that transformations of yeast cells were performed as described by Elble (1992 The GALl0 gene was disrupted by transplacement of a mutated version of gall0. The wild-type strain was transformed with the plasmid pBM58(URA3) (a generous gift from Mark Johnston) linearized with PvuII; gal-colonies were then recovered on 5-fluor-orotic acid (FOA) plates to select for transplacemeuts.
Cell Biology Protocols
FACS analysis was performed on mid-log phase cultures as described previously (Lew et al., 1992) .
Centrifugal elutriations were performed as previously described (Lew et al., 1992) . Cells were grown to mid-log phase in YEPR medium and elutriated G1 cells from wild-type and mutant strains were inoculated into prewarmed YEPD medium at time 0 rain. Aliquots were then taken every 15 rain to analyze the following parameters: the timing of START was determined by incubating an aliquot of the culture at 30°C in the presence of a-factor (200 ng/ml, final concentration) for 45 min and the percentage of the cells that had passed START was determined by FACS analysis; the percentage of cells that had entered into S phase was estimated by FACS analysis; the budding index was evaluated by visually scoring a minimum of 200 cells; the timing of nuclear division was determined by counting the number of cells with two separated nuclei after staining with DAPI.
Nuclei were visualized with DAPI according to the following protocol: cells from mid-log phase cultures were fixed for 30 rain in methanol:acetic acid (3:1) at room temperature, washed with 0.15 M NaC1, and stained for 30 rain in the dark with 0.1 mg/ml DAPI.
Actin and chitin staining and in vivo labeling with FITC-ConA were performed as previously described (Adams and Pringle, 1991; Pringle, 1991; Lew and Reed, 1993) .
Immunolocalization of the Bedl HA-tagged protein was performed as previously described with the following modifications: cells from mid-log cultures were fixed with 3.7% formaldehyde added directly to the medium and incubated for 1 h at room temperature or overnight at 4°C; the cells were washed once with PBS and twice with 1 M Sorbitol/1 mM EDTA. The cell wall was then digested with Zymolyase (ICN Biochemicals, Costa Mesa, CA) in the presence of [3-mercaptoethanol. Spheroplasts were washed twice with 1 M Sorbitol/1 mM EDTA, treated with 1% NP-40 for 5 min at room temperature and washed twice in 1 M Sorbitol/1 mM EDTA. Staining was performed on spheroplasts attached to poly-lysine--coated slides as previously described with the 12CA5 monoclonal antibody (Boehringer Mannheim Corp., Indianapolis, IN) at a concentration of 5 ng/ml. The secondary antibody was an FITC-conjugated goat serum directed against whole mouse IgG.
Protein Analysis
Protein extracts and cell fractionation were performed as described previously (Graham et al., 1994) . Cells from mid-log phase cultures were spheroplasted with Zymolase and lysed to obtain total protein extracts with intact membrane structures. These extracts were then centrifuged for 15 min at 13,000 g to generate the P13 fraction and the supernatant was centrifuged at 100,000 g to obtain the P100 and the S100 fractions. The HA-tagged Bedl fusion proteins were detected by Western blotting using the 12CA5 monoclonal antibody with the ECL detection kit (Amersham Corp., Arlington Heights, IL) as previously described (Grandin and Reed, 1993) . Kar2 was detected with a rabbit serum kindly provided by M. Rose.
Results
Overexpression of the mitotic cyclins Clbl or Clb2 under control of the GALl promoter is not lethal in S. cerevisiae.
The cells are only delayed in mitosis, presumably because the mitotic cyclin destruction pathway is sufficient to overcome the resultant elevated cyclin levels (Stueland et al., 1993; Amon et al., 1994) , thus avoiding deleterious effects to the cell. We took advantage of these observations to implement a screen for mutants unable to tolerate high levels of Clb2 expression (see Materials and Methods). Cells carrying an inducible CLB2 allele under the control of the GALl promoter (GY-1) were mutagenized by UV irradiation and we selected mutants that were unable to grow on YEPG which induces the GALI:CLB2 allele. Two categories of mutations are expected from such a screen. First, cells affected in their ability to degrade mitotic cyclins will arrest in mitosis because they cannot overcome the accumulation of CLB2 leading to chronic activation of the mi-totic form of Cdc28 kinase. This situation would be analogous to the lethality observed when a nondegradable form of Clbl (ClblA152) is overexpressed in wild-type cells (Ghiara et al., 1991) . A second expected class of mutation conferring a defect in bud emergence or growth polarity can also be obtained with this screening method. Delays or blocks in generation of growth polarity or in bud emergence are detected by a morphogenesis checkpoint leading to a temporary G2 arrest (Lew and Reed, 1995a) . This control can be overridden either by mutation of tyrosine 19 of the Cdc28 kinase or the overexpression of mitotic cyclins Clbl or Clb2 (Lew and Reed, 1995a) . Therefore mutations that delay budding or the generation of growth polarity could confer a lethal phenotype when CLB2 is overexpressed due to abrogation of the checkpoint. In this situation, cells dependent on the checkpoint would die with more than one nucleus as a result of mitosis occurring before budding. Eight mutations belonging to six complementation groups were isolated from the screening of 25,000 mutagenized colonies (see Materials and Methods for more detailed description of the screening procedure). The first mutation that we characterized was a mutated allele of the previously described VRP1 gene (Donnelly et al., 1993) . This gene encodes verprolin, a proline-rich protein required for proper actin organization. The fact that we recovered VRP1, a gene presumably involved in growth polarity and bud emergence, indicated that the screening method was effective for identification of genes involved in growth polarity and bud emergence. We then studied in greater detail the bed1-1 mutation; the gene defined by this mutation and the encoded protein are the subject of this paper.
A bedh:URA3 Strain Is Defective in Bud Emergence and the Morphogenesis Checkpoint Is Necessary for Its Viability
Although a GALhCLB2-bedl-1 strain was able to grow on dextrose medium (GAL promoter repressed) and not on galactose medium (GAL promoter induced), a bed1-1 strain was viable on both media. FACS analysis of nuclear DNA content of a strain overexpressing Clb2 in a bed1-1 background showed that a large fraction of the ceils were arrested with a 4N DNA content ( Fig. 1) while Clb2 overexpression in a wild-type background induced only a delay in mitosis (Stueland et al., 1993) . Microscopic observation revealed that a large proportion of the cells had more than two nuclei (see below for detailed analysis of the bedl phenotype). The BED1 gene was cloned, sequenced, and a null mutation in the BED1 gene was created by the onestep disruption method. The cloned gene was shown to be genetically linked to the BED1 locus (see Materials and Methods and below). We observed that the mutation and the targeted disruption conferred similar phenotypes and therefore used the bedl::URA3 strain to investigate the bed1 phenotype in detail. This strain was viable but showed a 30% reduction in growth rate in rich (YEPD) liquid medium compared to the isogenic wild-type strain. The cells were larger than wild-type and almost completely round, having lost the ellipsoidal morphology characteristic of S. cerevisiae (Fig. 2 B) . Using a Coulter Channelizer, bedh:URA3 cells were shown to be 50% larger than wild-type cells in rich medium (the mean cell volume for bedl:.'URA3 cells was 64 fl vs 42 fl for wild-type cells), bedl:.'URA3 cells also had defects in cell separation, in that cultures contained clumps of aggregated cells which could not be completely disrupted by sonication (see Fig. 2 B) . However, treatment with the cell wall-digesting enzyme Zymolyase gave single cells (not shown), indicating that the defect was in cell separation rather than cytokinesis. FACS analysis of bedh: URA3 cells showed an increase in the proportion of S/G2/M cells in an asynchronous culture in rich liquid medium. A small fraction of the cells scored as greater than 2N in DNA content, presumably because of the cell separation defect (Fig. 2 A) . In wild-type cells, bud emergence is concomitant with the beginning of S phase as is illustrated by the correlation between the budding index and the percentage of cells that have entered or completed S phase. This was not the case in bedl::URA3 mutants: in YEPR medium, the percentage of budded cells was lower than the percentage of cells that had entered or completed S phase despite the fact that the budding index was most likely overestimated due to the excessive aggregation associated with the strain (Fig. 2 A) . These observations were suggestive of a defect in bud emergence conferred by the bedl :: URA3 mutation.
To further characterize this phenotype, small G1 wildtype and bedl::URA3 cells were isolated by centrifugal elutriation, inoculated into fresh YEPD medium and execution of START, initiation of S phase, bud emergence, and nuclear division were followed (Fig. 3) . As previously described (Lew et al., 1992) , in the 15D wild-type background, completion of START was followed by S phase and bud emergence within 15-20 min. Nuclear division then occurred 45-50 min later. In bedl disruptant cells,
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completion of START occurred sooner than in wild-type cells, presumably because the elutriated population exhibited a larger size than the wild-type controls (not shown). S phase began normally 15-20 rain after START but bud emergence was delayed by more than an hour. Nuclear division took place very rapidly after bud emergence, within 10-15 min, suggesting that the morphogenesis checkpoint delays mitosis only until a bud forms to receive the daughter nucleus. Only a small fraction of bedh:URA3 cells contained more than one nucleus whereas most of the cells overexpressing Clb2 in this background became multinucleated (Fig. 4) . This is consistent with the fact that the overexpression of Clb2 or Clbl is lethal in bedl-1 or bed1:: URA3 cells (Fig. 1 A and Fig. 2 B ; not shown). In a synchronized culture, these cells went through S phase and mitosis before bud emergence and died with more than two nuclei (not shown). The disruption of the BED1 gene in the context of the cdc28 F19A18 mutation (where CDC28 is mutated so as to be no longer subject to negative regulatory phosphorylation) was not lethal but a large fraction of the cells were multinucleated (Fig. 4) . It was difficult to quantify the percentage of multinucleated cells in these different strains because of the cell aggregation phenotype, but it was clear that more multinucleated cells were detected when Clb2 was overexpressed or Cdc28 was not phosphorylatable. It was also apparent that, in bed1:: URA3 cells, nuclear division occurred very rapidly after bud emergence, in that daughter nuclei were observed even in very small buds while nuclear division took place in wild-type cells when buds were much larger (Fig. 4) . We 
bedl::URA3 Cells Have Defects in Polarized Growth Although Actin Is Properly Polarized
The fact that bed1 mutant cells are delayed in bud emergence, are large, and have an unusually round morphology, suggested that they might be defective in polarized growth during the cell cycle. This type of phenotype is often associated with an inability to properly organize the actin cytoskeleton (see Discussion). We investigated this possibility by looking at actin localization by rhodaminephalloidin staining of bed1 mutant cells. As shown in Fig. 5 A, actin staining revealed a pattern similar to that observed in wild-type cells: actin rings were observed at the pre-bud site and after bud emergence, actin patches were found exclusively in the buds and actin cables were oriented toward the tips of the buds. Finally actin patches were relocalized to the necks of the buds during cytokinesis. We also observed, as with wild-type cells, that actin patches were concentrated to the tip of the growth projection (shmoo) when bed1 mutants were treated with the mating pheromone a factor (not shown).
We then determined the timing of polarization of the actin cytoskeleton during the cell cycle in a synchronized culture (Fig. 3) . bed1 mutant cells began to undergo actin polarization within 5 min after completing START, as in wild-type ceils. We concluded, therefore, that actin was properly polarized at the appropriate time during the cell cycle, indicating that the bed1 phenotype does not result from an inability to reorganize the actin cytoskeleton at the G1/S phase boundary.
On the other hand, staining of bed1 mutants with calcofluor, a stain for chitin, which is normally found concentrated in the neck region of a budded cell and in "scars" on cells where previous buds were located, revealed that chitin was now completely delocalized and deposited at elevated levels (Fig. 5 B) . One interpretation of this phenotype is that bed1 mutants are defective in polarized secretion required for proper localization of chitin synthase despite the fact that there is no obvious defect in polarization of the actin cytoskeleton.
Growth polarity can be directly visualized by pulselabeling ceils with FITC-ConA, which binds mannose residues from the cell wall and chasing in the absence of FITC-ConA (for a more detailed description of this method, see Lew and Reed, 1993) . Exponentially growing wildtype and bedl::URA3 cells were pulse labeled and fixed after a chase of one generation equivalent in fresh medium. Daughter ceils originating from labeled buds (cells with an unlabeled birth scar) were scored for staining patterns characteristic of isotropic growth (uniform staining; see, for example, cell 1 in Fig. 6 A) or apical growth (staining that fades out toward one end of the cell; see, for example, cell 2 in Fig. 6 A) . As previously described , N40% of the daughter ceils from a wild-type population in YEPD medium exhibited polarized growth (169 out of 449 daughter cells). Among the cells exhibiting a pattern indicative of polarized growth, 15% showed a partial gradient of the staining where the pole of the cell was still detected (see cell 3 in Fig. 6 A; 27 out of 169). On the other hand, most of the bedl::URA3 daughter cells (N60%; 275 out of 452 daughter cells) exhibit a uniform staining indicative of completely isotropic growth (cell 4) and no daughter cells with completely unlabeled poles indicative of apical growth were observed. However, N15% of these cells (66 out of Figure 6 . FITC-ConA pulse labeling of wild-type and bed1 cells. (A) Wild-type (DLY-005) and bedl mutant (GY-647) diploid cells were pulse labeled with FITC-ConA for 15 min and after a chase with fresh medium during one generation time, cells were fixed and observed by fluorescence microscopy. Daughter cells generated from labeled buds with an unlabeled birth scar (indicated by an arrow) were scored for uniform staining indicative of an isotropic growth (cell 1), for staining that fades completely out toward the pole opposite from the unlabeled birth scar, indicative of polarized growth (cell 2) or for an incomplete or partial gradient toward the end of the daughter cell (cell 3). In the mutant population, daughter cells exhibiting uniform staining (cell 4) or an incomplete gradient toward one pole of the cell (cell 5) could be observed along with cells showing a weak uniform staining with brighter signal around the birth scar (cell 6). Bar, 10 Ixm. (B) Confocal microscopy was used to characterize the staining of the same cells in greater detail. Examples of staining indicative of polarized growth in wild-type cells are shown on the left. Mutant daughter cells exhibiting weak uniform staining with brighter staining around the birth scar or partial fade-out staining are shown on the right. Bar, 5 I~m. Fig. 6 A) . We used confocal microscopy to analyze the fade-out staining in greater detail (Fig. 6 B) . While no staining could be detected at the opposite pole of the unlabeled birth scar in wild-type cells, the end of bed1:: URA3 daughter ceils was always stained, suggesting that the apical growth, when it occurs, is defective or incomplete. Examination of cells with a stronger signal around the birth scar (cell 6 in Fig. 6 A) showed that the pattern is consistent with staining of a region very close to the scar itself but without any gradient toward the pole of the cell. Our interpretation is that growth cannot occur in this region for mechanical reasons and therefore the signal cannot be diluted during bud growth and appears as a narrow ring of heavily stained cell wall. The fact that we could still detect in some cells a partial gradient toward one pole of the cell (~15% of daughter cells) suggests that growth may be partially polarized at some point of the budding phase. Taken together, these results suggest that bedh: URA3 cells exhibit some growth polarity but that apical growth is not as efficient as in wild-type cells.
Molecular Characterization of the BED1 Gene: BED1 Shows Similarity to an S. pombe Gene Encoding an a-l,2-Galactosyltransferase
The gene encoding Bed1 was cloned by complementation of the GALhCLB2-bedl-1 mutant strain (GY-159) using a centromeric yeast genomic DNA library and two plasraids containing a 2.7-kb overlapping region were recovered (Fig. 7 A) . We detected one large open reading frame (ORF) in this region with a capacity for encoding a protein of 393 amino acids (Fig. 7 B) . Examination of the sequence of the BED1 gene showed a stretch of hydrophobic amino acids in the NH2-terminal portion of the ORF (residues 47 to 67; Fig. 7 B) . The inferred structure of Bed1 was reminiscent of the organization of type II membrane proteins: a short NH2-terminal cytosolic domain, a unique hydrophobic transmembrane domain (15-20 aminoacids) and a large luminal COOH-terminal domain (for review see High and Dobberstein, 1992) .
BED1 had similarity to the recently cloned gmal2+gene of S. pombe (Chappell et al., 1994) . The two proteins are similar in their predicted luminal domains: 4 regions that show ~30% identity and up to 70% similarity (Fig. 8) . The structures of these two proteins are different in that, although they both have type II membrane protein structure, the cytoplasmic domain of Bedl is larger (45 amino acids) than the corresponding domain of gmal2p (only two amino acids amino terminal to the transmembrane domain). The gmal2 ÷ gene encodes an ct-l,2-galactosyltransferase involved in the synthesis of the S. pombe cell wall which, in contrast to that of S. cerevisiae, contains glycoproteins with galactose residues. More recently, two putative ORF homologous to gmal2p were detected on chromosome I of S. pombe. Therefore, gma12 ÷ belongs to a highly conserved family of proteins that are conserved along their entire lengths in the fission yeasts S. pombe and S. octosporus ( Fig. 8 ; Chappell, T., personal communication).
We also noticed that Bedl is even more homologous to a previously unidentified S. pombe partial ORF present adjacent to the vacuolar H+-ATPase, subunit B gene (Fig.  8) . Analysis of the sequences available shows that the homology between Bed1 and this partial ORF is significantly greater than that between Bedl and gmal2p (see Fig. 8 ).
The structure of this ORF is also more similar to the structure of Bedl in that the putative cytoplasmic domain contains ~40 amino acids. However, the role of the protein represented in part by this ORF is not known. The possible implications of these homologies will be discussed below.
Bedl Is a Type H Membrane Protein Localized in the Endoplasmic Reticulum
Since the analysis of bedl::URA3 cells suggested a role in polarized secretion and Bed1 had a predicted structure organization consistent with a membrane protein, we determined the intracellular localization of Bed1. We introduced a COOH-terminal triple influenza hemagglutinin ([HA]3X)-tagged version of Bed1 into bedh:URA3 cells. The HA-specific 12CA5 monoclonal antibody detected a Figure 8 . Homologies between BED1 and gma12 ÷, an S. pombe gene encoding an et-l,2-galactosyltransferase. The search for sequences homologous to Bedl was performed at the National Center for Biotechnology Information (NCBI) through the GENINFO (R) BLAST Network Service (Blaster) (Altschul et al., 1990) . Four S. pombe ORFs were identified: gmal2p (SPA12GATR; accession number zQ09174), two ORFs on chromosome I (cdsll and cdsl3; accession number z49811) and a previously unidentified partial ORF (spORF) located 5' from the vacuolar H+-ATPase, subunit B gene (SPVATPB). The alignment of the 50RFs was established with the following rules: G=A=P=S; S=A=T; R=H=K; D=E; Q=N; M=I=L=V=F; F=W=Y. doublet on Western blots of approximate molecular mass of 50 kD, in good agreement with the predicted molecular weight of the fusion protein (46 kD for Bedl and 4 kD for the [HA]3X tag) (Fig. 9 A) . The HA-tagged version of BED1 was able to rescue the defects associated with the disruption of BED1 (not shown). Thus, we concluded that the fusion protein was functional. Crude fractionation of extracts containing intact membrane structures showed that Bedl[HA]3X was present in the low speed fraction (P13) enriched for endoplasmic reticulum, nuclear envelope, vacuoles, and plasma membrane. Kar2, a luminal protein of the ER (Rose et al., 1989) , was also mainly present in this fraction, as expected. We also showed that, unlike Kar2, Bedl was tightly associated with membranes: Bedl remained membrane associated after treatment of the membrane fraction with carbonate pHll.0 but not after treatment with detergents (not shown). Moreover, only the NH2-terminal portion of Bedl was sensitive to proteolysis by proteinase K when the protein was associated with intact membranes, suggesting that the first 45 amino acids are likely to be cytosolic in intact cells (not shown). Based on these criteria, we concluded that Bedl is a type II integral membrane protein.
We were unable to detect Bedl [HA]3X by immunofluorescence when the fusion protein was expressed under the control of its native promoter (not shown). Therefore, we constructed a strain containing the tagged protein under control of the constitutive GAP promoter (GY-718), yielding a 20-fold increase in the amount of Bedl protein, as observed by Western blot (Fig. 9 A) . Since it has been shown that, in some cases, overexpression of proteins of the secretory pathway can lead to a mislocalization due to saturation effects, we verified that Bedl had the same fractionation profile when overexpressed as when it was expressed under control of its own promoter (Fig. 9 A) . We observed an immunofluorescenee staining pattern consistent with an ER localization of the protein: the signal was perinuclear with some extensions into the cytoplasm. This pattern was similar to the immunolocalization of Kar2, a luminal protein of the endoplasmic reticulum (Rose et al., 1989) . We also observed that Bedl colocalized with Kar2 in individual cells (not shown). These data taken together suggest that Bedl is a type II integral membrane protein of the endoplasmic reticulum and support the hypothesis, based on homologies with gmal2 ÷, that Bedl is a galactosyltransferase and that the switch to polarized secretion might require galactosyl modification of particular proteins or lipids during transit through the endoplasmic reticulum.
Discussion
The BED1 gene was identified based on its involvement in bud emergence and polarized growth in S. cerevisiae. Although impaired, cells disrupted for BED1 are viable, suggesting either that this gene encodes an important but nonessential function, or that BED1 is redundant with another related gene. Bud emergence was strongly delayed, occurring only 1 h after initiation of S phase in bedl:: URA3 cells while these two events were tightly coupled in wild-type cells. On the other hand, nuclear division took place immediately after bud emergence, indicating a tight coupling between these two events in bed1 mutant cells.
However, bed1 cells became multinucleated when the mitotic form of Cdc28 was hyperactivated by either the overexpression of the mitotic cyclins Clbl or Clb2 or by mutation of Tyrl9, the regulatory phosphorylation site of Cdc28. Lew and Reed (1995a) have shown that, while the G2 delay induced by defects in growth polarity or budding can be completely abolished by Clbl or Clb2 overexpression, the cdc28 rw mutation only reduces the delay but cannot eliminate it completely. This accounts for the observation that a bedl::URA3-cdc28 F19Als strain is viable while overexpression of Clb2 in a bedl::URA3 background is lethal. Taken together, these observations suggest that the viability of bedl cells depends on the morphogenesis checkpoint machinery which is able to delay mitosis in the absence of budding in order to maintain the coordination between the nuclear division cycle and the budding cycle. In fact, the dependence of the bed1 mutant on the morphogenesis checkpoint for survival is the most convincing demonstration of the importance of this regulatory system in the yeast life cycle. Finally, cells disrupted for BEDI exhibited morphological aberrations, losing the ellipsoidal shape characteristic of S. cerevisiae and being larger than wild-type cells. In addition, bed1 cells had defects in cell separation as indicated by a tendency to form aggregates in liquid medium.
The delayed bud emergence, the morphological and morphogenetic phenotypes observed in bedl::URA3 cells (increased size, round cell shape, and delay in bud emergence) could be a result of defects in secretion or the generation of growth polarity by analogy with other morphogenesis mutants (for reviews see Bretscher et al., 1994; Welch and Drubin, 1994) . Disorganization of the actin cytoskeleton and delocalized deposition of chitin are usually phenotypically coupled, presumably because proper actin function is required for polarized secretion and therefore for budding. In bedl::URA3 cells, actin polarization after START and actin reorganization at cytokinesis occurred on schedule. Surprisingly, however, chitin deposition was greatly increased and completely delocalized, indicating that bed! cells have defects in polarized growth. Moreover, a more direct evaluation of growth polarity by in vivo pulse labeling with FITC-ConA showed that bed1:: URA3 cells are defective in the most polarized form of growth, growth directed to the bud tip or apical growth. Some residual growth polarity was observed, explaining why bedl::URA3 cells are viable and suggesting that another gene redundant with BED1 might be responsible for this activity. From these observations, we suggest that bed1 cells are impaired in directing secretory vesicles to the bud site but not in secretion per se, and that Bedl is part of a pathway that is downstream or parallel to the actin pathway; both pathways being necessary for proper delivery of secretory vesicles to the bud site during bud emergence and to the bud neck during cytokinesis and cell separation.
A role in polarized secretion is also consistent with the intracellular localization of Bedl. Crude fractionation of whole cell lysates showed that Bedl was present in a low speed fraction containing endoplasmic reticulum, vacuoles, nuclear envelope, and plasma membranes. Biochemical experiments indicated that Bed1 was an integral type II membrane protein with a small NH2-terminal cytoplasmic Figure 9 . Bedl is a membrane protein localized in the endoplasmic reticulum. (A) Bed1 is present in an ER-enriched fraction. Total protein extracts (TOTAL) containing intact membrane structures were subjected to a crude fractionation procedure: the P13 fraction is enriched for membranes from the endoplasmic reticulum, the vacuoles, the plasma membrane and the nuclear envelope; the P100 fraction is enriched for Golgi membranes; the S100 fraction contains soluble proteins. sures of the Western blots that 40% of Kar2 was in the P13 fraction, 20% in the P100, and 20% in the S100 fraction. The same kind of measurement gave for Bedl 90%, 10%, and less than 1% in fractions P13, P100, and S100, respectively. (B) Immunolocalization of domain and COOH-terminal luminal domain. The predicted structure of the protein was in agreement with this conclusion since Bedl contained a putative hydrophobic transmembrane domain in the NH2-terminal portion of the protein (amino acids 47-67). We were not able to detect an epitope-tagged version of the protein expressed from its own promoter by immunofluorescence because of low levels of expression but a staining pattern suggesting an ER localization for Bedl was obtained when the tagged protein was overexpressed. We showed however that the behavior of Bed1 in the fractionation procedure we used was not affected by overexpression from the constitutive GAP promoter. Taken together, these two different approaches suggested that Bedl is an integral type II membrane protein of the ER.
We discovered recently that the BED1 gene was independently cloned as SLC2 (Karpova et al., 1995) . sic2 mutants were identified during a screen designed to identify mutations synthetically lethal with a disruption of CAP2, a gene involved in actin cytoskeleton organization (Karpova et al., 1993) . The phenotype associated with the slc2-I07 is different from that described here: the actin cytoskeleton is disorganized in a strain carrying the slc2-107 allele and this strain is thermosensitive while bedl::URA3 cells have a normal pattern of actin polarization and are not temperature sensitive (at least up to 37°C; not shown). This could be explained either by strain background differences or by the fact that the slc2-107 mutation is semidominant, suggesting that this mutation might be associated with a gainof-function. More recently, the sequence of the BED1 gene appeared twice in the Genbank database: it was detected during the sequencing of chromosome IV and BED1 is identical to MNNIO (accession number 142540). mnn mutants were isolated as mutants that have aberrant carbohydrate structures in the cell wall; most of the gene products are thought to be involved in mannosylation of proteins but some could be involved in more general functions of the secretory pathway that might affect mannosylation indirectly (for review see Hercovics and Orlean, 1993) . This latter hypothesis is consistent with our results.
BED1 was found to be similar to 4 ORFs in S. pombe, gma12 ÷, and 2 of its homologues and a previously unidentified ORF we called spORF. The homology between Bedl and gmal2p/cdsl 1/cdsl3 was particularly significant over 4 regions in the luminal portion of these proteins (~30% identity and 65 % similarity). The gmal2p protein has been shown to be an a-l,2-galactosyltransferase (Chappell et al., 1994) . Several galactosyltransferase activities have been detected in S. pombe (Chappell et al., 1994; Ballou and Ballou, 1995) and the grna12 ÷ gene belongs to a large family of related genes in S. pombe (Chappell, T., personal communication) . Although the structures of the two proteins are clearly similar, Bedl has a larger cytoplasmic domain. On the other hand, this domain is comparable in size with the corresponding domain of spORF and, furthermore, comparison of the available sequences of spORF and Bed1 (see Fig. 7 ) showed that the degree of similarity between Bedl and spORF was higher than between Bedl and gmal2p (~40-50% identity and 70% similarity). We conclude from these observations that spORF is more likely than gmal2 ÷ to be the homologue of BED1 in S. pombe. Indeed, gmal2 + could not complement the morphological defects observed in bed1 cells, although it was shown to be enzymatically active in vitro in extracts from S. cerevisiae ceils overexpressing gmal2p under the control of the GALl promoter (not shown). Moreover, localization of gmal2p in the Golgi apparatus (Chappell et al., 1994) is distinct from that of Bedl. Finally, gma12p is involved in bulk modification of proteins of the cell wall, a phenomenon particular to S. pombe, that has not been detected in S. cerevisiae; we propose that the role of Bedl is more specific (see below).
It was surprising to find homology between Bedl and a galactosyltransferase since, to our knowledge, no galactosyl modifications have been described for glycoproteins or glycolipids in S. cerevisiae. We were unable to detect any galactosyltransferase activity in extracts from wild-type cells or from cells overexpressing Bedl under conditions where ectopically overexpressed gmal2p showed significant activity (not shown). This assay, based on conditions described for gmal2p (Chappell and Warren, 1992) , is somewhat restrictive and does not rule out the possibility that Bedl could be a galactosyltransferase that cannot use et-methylmannoside or a-methylgalactoside as an acceptor. Furthermore, the idea that Bedl is a galactosyltransferase is in conflict with the fact that no phenotype has been described in association with disruption of the GALIO gene encoding UDP-glucose 4-epimerase, the enzyme responsible for interconversion of UDP-glucose and UDP-galactose. We verified that the disruption of this gene in our genetic background did not confer a morphological phenotype similar to that of bedl::URA3 cells when grown on glucose medium (not shown). An alternative possibility is that another epimerase is present in S. cerevisiae and is responsible for the production of UDP-galactose from UDP-glucose for the purpose of galactosyl modification of specific proteins or lipids. Such modification targeted to specific protein or lipid species could have escaped detection in analysis of bulk glycoproteins or glycolipids. This raises the intriguing possibility that specific galactosyl modification may be involved in signaling the isotropic to polarized switch in secretion. We are currently investigating using a PCR approach the hypothesis that S. cerevisiae contains other glucose-4-epimerase(s). Alternatively, Bedl may catalyze a different glycosyl modification although, based on precedent, this is unlikely: high levels of structural homology have been detected only between enzymes that catalyze analogous glycosylation reactions (Kleene and Berger, 1993) .
A simple model to explain the role of Bed1 in polarized growth and therefore in bud emergence is that Bedl is involved in modification of an effector protein that controls the targeting of the secretory vesicles via the actin cytoskeleton in the context of the switch from isotropic to polarized growth at the G1/S phase boundary. In an alternative model, Bedl might catalyze a modification that leads to local reorganization of the membrane and/or the cell wall at the bud site, allowing vesicles to fuse more efficiently with the plasma membrane. Elucidation of the function of Bedl will require the identification and characterization of its target(s).
It is interesting that bed1 mutant cells show defects in polarized secretion and that cell division occurs when buds are unusually small (Fig. 4) . One interpretation of this ob-servation is that bud emergence, albeit with a delay, can be initiated without highly polarized secretion but that, under such circumstances, significant growth cannot occur until a bud becomes an autonomous cell. Thus, whereas bud growth is normally integrated as a phase of each cell cycle, in bedl cells, it may be pushed forward to the subsequent cell cycle.
In summary, we have characterized a new gene that is required for efficient bud emergence and apical growth. Cells carrying a disrupted allele of BED1 are viable but depend upon a morphogenesis checkpoint to survive. The defects observed in bedl cells indicate that this protein is in a pathway downstream or parallel to the actin polarization pathway in mediating the switch from isotropic to polarized growth. The fact that Bedl shares significant homology with an S. pombe galactosyltransferase suggests that glycosylation might have an important signaling role in this process.
